Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Debt to Equity (2016 - 2025)

Bio-Techne has reported Debt to Equity over the past 12 years, most recently at $0.13 for Q4 2025.

  • Quarterly results put Debt to Equity at $0.13 for Q4 2025, down 10.42% from a year ago — trailing twelve months through Dec 2025 was $0.13 (down 10.42% YoY), and the annual figure for FY2025 was $0.18, up 16.95%.
  • Debt to Equity for Q4 2025 was $0.13 at Bio-Techne, down from $0.15 in the prior quarter.
  • Over the last five years, Debt to Equity for TECH hit a ceiling of $0.23 in Q4 2023 and a floor of $0.11 in Q4 2022.
  • Median Debt to Equity over the past 5 years was $0.16 (2022), compared with a mean of $0.17.
  • Biggest five-year swings in Debt to Equity: plummeted 56.54% in 2021 and later skyrocketed 107.97% in 2023.
  • Bio-Techne's Debt to Equity stood at $0.17 in 2021, then tumbled by 33.94% to $0.11 in 2022, then skyrocketed by 107.97% to $0.23 in 2023, then plummeted by 36.6% to $0.14 in 2024, then dropped by 10.42% to $0.13 in 2025.
  • The last three reported values for Debt to Equity were $0.13 (Q4 2025), $0.15 (Q3 2025), and $0.18 (Q2 2025) per Business Quant data.